The Obama administration’s compromise ignores scientific studies confirming the safety of the emergency contraceptive drug for women of all ages
In 2011, days after the FDA approved Plan B, U.S. Health and Human Services Secretary Kathleen Sebelius vetoed the decision, barring over-the-counter sales of the pill to girls younger than 17.
Responding to an April mandate from a federal district court that would make the emergency contraception drug Plan B available without a prescription to all women regardless of age, the Obama administration reduced current age restrictions on the pill from 17 to 15.
That political compromise, despite being the U.S.’s most progressive legislation on emergency contraception to date, continues a historical pattern of ignoring the very studies U.S. administrations have ordered to evaluate the safety of the drug and the societal effects of increased access to emergency contraception.
For the rest of the story: http://www.scientificamerican.com/article.cfm?id=white-house-limits-plan-b-put-science-backseat